药物治疗门静脉系统血栓形成的疗效

摘要
图/表
参考文献
相关文章 (10)

全文: PDF (1229 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：评价门静脉系统血栓形成药物治疗的效果。方法：回顾性分析2011年4月至2016年4月温州医科大学附属台州医院收治的19例经药物治疗的门静脉系统血栓形成患者的临床资料。结果：19例患者通过低分子肝素钙联合华法林治疗，均恢复良好，平均住院时间（12±5）d，平均随访（20±9）个月，无复发。结论：对于没有腹膜刺激症状的门静脉系统血栓形成患者，药物保守治疗是安全有效的。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	虞哲科
	王晶晶
	邱振明
	赵铮铮
	郑永华

关键词 ：门静脉, 静脉血栓形成, 抗凝, 溶栓

Abstract：Objective: To evaluate the effectiveness of drug therapy for portal vein thrombosis. Methods: A retrospective analysis was conducted on the clinical data of 19 patients with portal vein thrombosis treated with drug from April 2011 to April 2016 at Taizhou Hospital Affiliated to Wenzhou Medical University. Results: All 19 patients who were treated with low molecule Gansugai and Warfarin recovered well. Their average hospital stay was (12±5) d and average follow-up (20±9) months without recurrence. Conclusion: Conservative treatment with drugs is safe and effective for patients with portal vein thrombosis and without peritoneal irritation.

Key words： portal vein venous thrombosis anticoagulant therapy thrombolysis

收稿日期: 2017-07-15

作者简介: 虞哲科（1979-），男，浙江舟山人，副主任医师，硕士。

链接本文:

https://xb.wmu.edu.cn/CN/ 或 https://xb.wmu.edu.cn/CN/Y2018/V48/I5/383

[1] KIM H S, PATRA A, KHAN J, et al. Transhepatic catheter-directed thrombectomy and thrombolysis of acute superior mesenteric venous thrombosis[J]. J Vasc Interv Radiol, 2005, 16(12): 1685-1691.
[2] CENEDESE A, MONNEUSE O, GRUNER L, et al. Initial management of extensive mesenteric venous thrombosis: Retrospective study of nine cases[J]. World J Surg, 2009, 33 (10): 2203-2208.
[3] KUMAR S, SARR M G, KAMATH P S. Mesenteric venous thrombosis[J]. N Engl J Med, 2001, 345(23): 1682-1688.
[4] HOLLINGSHEAD M, BURKE C T, MAURO M A, et al. Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis[J]. J Vasc Interv Radiol, 2005, 16(5): 651-661.
[5] SASAKI S, UEDA N, NAKANO T, et al. Portal and superior mesenteric venous thrombosis treated with thrombolytic therapy via the superior mesenteric artery and vern[J]. Nihon Shokakibyo Gakkai Zasshi, 2011, 108(1): 59-67.
[6] LUO J, YAN Z, WANG J, et al. Endovascular treatment for nonacute symptomatic portal venous thrombosis through intrahepatic portosystemic shunt approach[J]. J Vasc Interv Radiol, 2011, 22(1): 60-69.
[7] HAN G, QI X, HE C, et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis[J]. J Hepatol, 2011, 54 (1): 78-88.
[8] BRUNAUD L, ANTUNES L, COLLINET-ADLER S, et al. Acute mesenteric venous thrombosis: Case for nonoperative management[J]. J Vasc Surg, 2001, 34: 673-679.
[9] GRISHAM A, LOHR J, GUENTHER J M, et al. Deciphering mesenteric venous thrombosis: Imaging and treatment [J]. Vasc Endovascular Surg, 2005, 39(6): 473-479.
[10] CHAWLA Y, DUSEJA A, DHIMAN R K. Review article the modern management of portal vein thrombosis[J]. Aliment Pharmacol Ther, 2009, 30(9): 881-894.
[11] SCHOOTS I G, KOFFEMAN G I, LEGEMATE D A, et al. Systematic review of survival after acute mesenteric ischemia according to aetiology[J]. Br J Surg, 2004, 91(1): 17-27.
[12] 张莉, 王龙, 杨根妹. 肝硬化门静脉血栓形成的相关危险因素分析[J]. 中华消化杂志, 2014, 34(2): 100-104.